跳至主要内容
临床试验/NCT01112878
NCT01112878撤回4 期

Randomized, Double-Blinded, Placebo-controlled Study to Evaluate the Analgesic Efficacy of Oral Clonidine and Gabapentin as Part of a Multi-modal Analgesic Regimen for Preventing Pain After Arthroscopic Shoulder or Knee Surgery

Cedars-Sinai Medical Center1 个研究点 分布在 1 个国家开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
1
主要终点
Postoperative Pain using a Verbal Rating Scale (VRS)

研究概览

简要总结

The purpose of this research is to investigate the non-opioid (non-narcotic) pain-relieving medications clonidine and gabapentin to see if they decrease the amount of opioid pain medications needed after surgery, thereby reducing opioid-related side effects, and time required to return to normal activities of daily living after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled to undergo arthroscopic joint surgery
  • Willingness and ability to sign an informed consent document
  • No allergies to clonidine, gabapentin, anesthetic or analgesic medications
  • 18 - 80 years of age
  • American Society of Anesthesiologists (ASA) Class I - III adults of either sex
  • Women of childbearing potential must be currently practicing an acceptable form of birth control, and have a negative urine pregnancy test

排除标准

  • Patients with known allergy, hypersensitivity or contraindications to clonidine, gabapentin, anesthetic or analgesic medications
  • Patients with clinically-significant medical conditions, such as brain, heart, kidney, endocrine, or liver diseases, peptic ulcer disease or bleeding disorders
  • Patients with chronic hypertension or pain syndromes receiving clonidine or gabapentin, respectively.
  • Pregnant or lactating women
  • Subjects with a history of alcohol or drug abuse within the past 3 months
  • Patients taking any analgesic medications within 48 hours prior to the surgery
  • Any other conditions or use of any medication which may interfere with the conduct of the study
  • Non-English speakers
  • Patients greater than 80 years of age

研究组 & 干预措施

Sugar Pill

Placebo Comparator

Frequency and Dosage:

  • once in the preoperative holding area and once before discharge from PACU
  • continuation of 1 capsule twice daily with meals, 1 to 4 days after surgery.

干预措施: Gabapentin (Drug)

Sugar Pill

Placebo Comparator

Frequency and Dosage:

  • once in the preoperative holding area and once before discharge from PACU
  • continuation of 1 capsule twice daily with meals, 1 to 4 days after surgery.

干预措施: Clonidine (Drug)

Clonidine

Active Comparator

Dosage: 0.2 mg

  • once in the preoperative holding area and once before discharge from PACU
  • continuation of 1 capsule twice daily with meals, 1 to 4 days after surgery.

干预措施: Sugar pill (Drug)

Clonidine

Active Comparator

Dosage: 0.2 mg

  • once in the preoperative holding area and once before discharge from PACU
  • continuation of 1 capsule twice daily with meals, 1 to 4 days after surgery.

干预措施: Gabapentin (Drug)

Gabapentin

Active Comparator

Dosage: 600 mg

  • once in the preoperative holding area and once before discharge from PACU
  • continuation of 1 capsule twice daily with meals, 1 to 4 days after surgery.

干预措施: Sugar pill (Drug)

Gabapentin

Active Comparator

Dosage: 600 mg

  • once in the preoperative holding area and once before discharge from PACU
  • continuation of 1 capsule twice daily with meals, 1 to 4 days after surgery.

干预措施: Clonidine (Drug)

结局指标

主要结局

Postoperative Pain using a Verbal Rating Scale (VRS)

时间窗: 1 month

Outcomes will be measured with follow up questionnaires at 1, 2, or 3, then 7 and 30 days after surgery

次要结局

  • return to normal activities of daily living using follow up questionnaires(1 month)
  • Patient satisfaction using a verbal rating scale from 0 to 100(1 month)
  • Opioid consumption obtained from the recorded data(1 month)
  • postoperative nausea and vomiting using a Verbal Rating Scale(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ronald Wender

Chairman, Department of Anesthesiology

Cedars-Sinai Medical Center

研究点 (1)

Loading locations...

相似试验